Literature DB >> 1416394

Idiopathic pulmonary fibrosis. Quantitative assessment of lung pathology. Comparison of a semiquantitative and a morphometric histopathologic scoring system.

D M Hyde1, T E King, T McDermott, J A Waldron, T V Colby, W M Thurlbeck, W M Flint, L Ackerson, R M Cherniack.   

Abstract

The objective of this study was to determine the accuracy of a semiquantitative method of assessing the relative degree of cellularity and fibrosis compared with a morphometric analysis of specific histopathologic features in idiopathic pulmonary fibrosis (IPF). Morphometric analysis was performed on biopsy tissue from 20 patients. Morphometry showed that approximately 70% of parenchymal tissue was abnormal: 35% cellular consolidation and fibrosis, 20% honeycomb changes, 10% thick alveolar septa, and 5% small airways within abnormal parenchymal tissue. The prominent components of the abnormal parenchymal tissue were extracellular fibers, an abundance of interstitial cells, and epithelial cell hyperplasia. Correlation between four groupings of pathologic features, identified by a semiquantitative analysis, and each of the components of the parenchymal lesions showed significant correlations between (1) the fibrotic or reparative factor (alveolar wall metaplasia, fibrosis, honeycombing, and smooth muscle and vascular changes) and components of honeycomb lesions (extracellular fibers, interstitial cells, and epithelial injury and repair), and (2) the inflammatory and exudative factor and extracellular fibers in the lesions. These results support that the scoring system used by the pathology panel provides an accurate assessment of pathologic features useful in the assessment of the extent and severity of the histopathologic lesions of IPF.

Entities:  

Mesh:

Year:  1992        PMID: 1416394     DOI: 10.1164/ajrccm/146.4.1042

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  11 in total

Review 1.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

2.  Relationship between histopathological features and the course of idiopathic pulmonary fibrosis/usual interstitial pneumonia.

Authors:  L Tiitto; R Bloigu; U Heiskanen; P Pääkkö; V L Kinnula; R Kaarteenaho-Wiik
Journal:  Thorax       Date:  2006-06-12       Impact factor: 9.139

3.  Human mast cell basic fibroblast growth factor in pulmonary fibrotic disorders.

Authors:  Y Inoue; T E King; S S Tinkle; K Dockstader; L S Newman
Journal:  Am J Pathol       Date:  1996-12       Impact factor: 4.307

4.  Endothelin-1 in idiopathic pulmonary fibrosis.

Authors:  M Uguccioni; L Pulsatelli; B Grigolo; A Facchini; L Fasano; C Cinti; M Fabbri; G Gasbarrini; R Meliconi
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

Review 5.  Pulmonary fibrosis: patterns and perpetrators.

Authors:  Paul W Noble; Christina E Barkauskas; Dianhua Jiang
Journal:  J Clin Invest       Date:  2012-08-01       Impact factor: 14.808

6.  Expression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia.

Authors:  Tomoyuki Kakugawa; Hiroshi Mukae; Tomayoshi Hayashi; Hiroshi Ishii; Seiko Nakayama; Noriho Sakamoto; Sumako Yoshioka; Kanako Sugiyama; Mariko Mine; Yohei Mizuta; Shigeru Kohno
Journal:  Respir Res       Date:  2005-06-14

7.  Prognostic impact of preoperative serum alkaline phosphatase level on a composite of morbidity and mortality after thoracic endovascular aortic repair: A retrospective study.

Authors:  Sung Yeon Ham; Sang Beom Nam; Dong Woo Han; Ann Hee You; Won Sik Lim; Young Song
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

8.  The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium.

Authors:  Max A Seibold; Russell W Smith; Cydney Urbanek; Steve D Groshong; Gregory P Cosgrove; Kevin K Brown; Marvin I Schwarz; David A Schwartz; Susan D Reynolds
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

9.  Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern.

Authors:  Moisés Selman; Guillermo Carrillo; Andrea Estrada; Mayra Mejia; Carina Becerril; José Cisneros; Miguel Gaxiola; Rogelio Pérez-Padilla; Carmen Navarro; Thomas Richards; James Dauber; Talmadge E King; Annie Pardo; Naftali Kaminski
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

10.  Eosinophil alveolitis in two patients with idiopathic pulmonary fibrosis.

Authors:  Ninna Brix; Finn Rasmussen; Venerino Poletti; Elisabeth Bendstrup
Journal:  Respir Med Case Rep       Date:  2016-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.